Afpedia > Products >Chemicals >Biochemical Industry >Finished Medicine> GMP Certified Metronidazole Injection Small Volume Injection Pharmaceutical Transfusion

Supplier Details

  • Anhui BBCA Pharmaceutical Co.,Ltd.

  • This supplier is an uncertified member of Afrindex. To ensure your interest, Afrindex will first verify this supplier information before publishing his contacts.
  • Location: ******
  • Tel: ******
  • Mobile: ******
  • Email: ******

Service For Buyers

Hot Products

Sponsor Advertsing

GMP Certified Metronidazole Injection Small Volume Injection Pharmaceutical Transfusion

  • FOB Price : US $0.18-0.2
  • MOQ: 50000 bottles
  • Port : shanghai
  • Payment Terms : Western Union,T/T,L/C
  • Production Capacity: 100000 bottles/day


Add to My Basket You can manage your basket in member center

  • Basic Info
  • Company Profile
  • Packaging Details:carton
  • Origin:China
  • Model Number:BBCA18022607
  • Brand Name:BBCA

Product Description


    Pharmaceutical Metronidazole Infusion Glass Bottle Packing BBCA


    1. Product Name: Pharmaceutical Transfusion Glass Bottle packing Metronidazole Injection
    2.Component: This article main ingredients for metronidazole.
    3. Appearance: This product is colorless or nearly colorless transparent liquid.
    4. Indications: This product is mainly used for the treatment of anaerobic bacteria infection.
    5. Specifications: 100ml/250ml: 0.5g
    6. Usage and Dosage: Intravenous drip.
    A. Adults often usage: anaerobic bacteria infection, intravenous drug delivery for the first time in 15 mg body weight (70 kg adult is 1 g, 2 bottles), maintain the quantity according to the weight of 7.5 mg, intravenous drip every six to eight hours at a time.
    B. Children often usage: anaerobic bacteria infection with adult dose.
    7. Contraindications: Active central nervous system disorders and blood diseases is disabled.
    8. Pharmacological mechanisms:
    Quickly reach peak after intravenous drug delivery.Protein binding rate < 5%, after absorbing widely distributed in various tissues and fluids, and can pass the blood brain barrier, effective drug concentration can appear in saliva, placenta, bile, milk, amniotic fluid, semen, urine, pus and cerebrospinal fluid.Reports, drugs in the placenta and milk is similar to blood drug concentration, concentration of bile.Healthy blood drug concentration in cerebrospinal fluid in the blood drug concentration for the same period 43%.Concentration can last 12 hours.This product by the kidney from 60% to 80%, about 20% of the prototype drug from the eduction in urine, the rest to metabolites (25% glucuronic acid, 14% other metabolic binders) form of urine.10% with droppings.14% from the skin excretion.
    9. Storage: Protect from light, airtight preservation.
    10. Package: 100ml/glass bottle; 40 glass bottles/carton

Photo Show

  •  BBCA PHARMA, a subsidiary of BBCA Group, is the first pharmaceutical listed company in Anhui province (It was listed in Shenzhen Stock Exchange in 2000 and the Stock Code is 000153). Established for almost 60 years, BBCA PHARMA has successively earned a reputation of China’s Top 100 Pharmaceutical Industries for several years since 2006.

        Integrating R&D, manufacturing with sales, BBCA PHARMA has developed into a national high and new tech enterprise, leading with large-volume transfusion (the annual amount is over 500 million bottles/bags) and assisting by analgesic-antipyretic, cardiovascular, antibiotic products, etc. 53 international production lines certified by GMP, its products include more than ten kinds of dosage forms and 300 varieties of drugs, involving fields of bio-pharmaceutical, chemical pharmaceutical, Chinese Herbal Medicine and APIs.

        Employing more than 5,000 staff, the sales income of BBCA PHARMA has been over 3 billion. BBCA PHARMA owns seven pharmaceutical factories, one National Pharmaceutical R&D Center, six pharmaceutical marketing companies and one pharmacy chain with more than 600 pharmacies. In which, the international business company mainly engage in exporting business of APIs and preparations, importing raw materials, equipment procurement and registration of drugs. Varieties of preparations have been registered and marketed in Myanmar, Vietnam, the Philippines, Uzbekistan, Pakistan, Nigeria, Ecuador, Cameroon and many other countries.

       The APIs and preparations of BBCA PHARMA have been exported not only to developing countries and regions such as Asia, Africa and Latin America, but also to developed markets such as Europe, America, Japan and Korea.

      BBCA can provide technical services for your enterprise by utilizing the mature production technologies of various drugs, and provide the OEM servise as well.

  • More >

Basic Information

  • Chemicals-Biochemical Industry-Active Pharmaceutical Ingredient
  • BBCA
  • 1997-08-30
  • manufacturing enterprise
  • Main APIs“”Aspirin-DL-Lysine,Paracetamol,Sodium Lactate,Cefuroxime Axetil,D-Fructose,Propacetamol Hydrochloride and so on. Main Pharmaceutical Preparations:Propacetamol Tablets/Capsules,Sodium Chloride Injection,Oxytocin Injection,Metronidazole Injection,Levofloxacin Hydrochloride Capsules,Ceftriaxone Sodium for injection and so on.
  • Myanmar, Vietnam, the Philippines, Uzbekistan, Pakistan, Nigeria, Ecuador, Cameroon and many other countries.
  • >60%
  •  YES
Enter between 20 to 4,000 characters